Related Experiment Video
Updated: Jul 15, 2026
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
A study on dyslipidaemia in subclinical hypothyroidism
Sanjoy K Bandyopadhyay1, A K Basu, Salil K Pal
1Department of Medicine, NRS Medical College, Kolkata.
Journal of the Indian Medical Association
|April 21, 2007
Summary
Subclinical hypothyroidism (SCH) is linked to significant lipid alterations, including elevated cholesterol and triglycerides, particularly in older adults and women. Early detection and management of SCH are crucial for cardiovascular health.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Cardiovascular Health
Background:
- Subclinical hypothyroidism (SCH) is defined by elevated serum thyroid stimulating hormone (TSH) with normal free thyroid hormones.
- SCH affects a notable portion of the population, often presenting with non-specific symptoms.
- Lipid profile abnormalities are a known complication of thyroid dysfunction.
Purpose of the Study:
- To investigate the prevalence and patterns of serum lipid alterations in patients with stable subclinical hypothyroidism.
- To compare lipid profiles between SCH patients and age/sex-matched euthyroid controls.
- To analyze lipid changes based on age, sex, anti-thyroid peroxidase (anti-TPO) antibody status, and TSH levels.
Main Methods:
- A comparative study involving 100 patients with SCH and 52 euthyroid controls.
- Patients' ages ranged from 17 to 68 years, with 78% being female.
- Lipid parameters, including lipoprotein (a), total cholesterol, triglycerides, and low-density lipoprotein cholesterol, were analyzed.
Main Results:
- Significant elevations in total cholesterol, triglycerides, and low-density lipoprotein cholesterol were observed in SCH patients aged 40-50 years.
- Lipoprotein (a) was elevated in SCH patients over 20 years.
- Both anti-TPO positive and negative SCH subgroups showed higher triglyceride and LDL cholesterol levels; females exhibited more widespread lipid abnormalities than males.
Conclusions:
- Subclinical hypothyroidism is associated with significant dyslipidemia, varying by age, sex, and antibody status.
- These lipid alterations underscore the importance of monitoring cardiovascular risk factors in individuals with SCH.
- Further research into targeted interventions for lipid management in SCH is warranted.
Related Concept Videos
01:23Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...